Find policies, billing codes, payers, states, and providers
CPT 92523: Speech Sound Production Evaluation, SLP
CPT code 92523 designates an evaluation by a speech–language pathologist of a patient’s speech sound production, assessing articulation errors and phonological patterns. This code is used nationwide to document diagnostic assessment that informs therapy planning for speech sound disorders across the lifespan. Its proper use affects clinical documentation, coding accuracy, and payment for SLP services in multiple outpatient and institutional settings.
Key payers examined include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The analysis covers coverage considerations and coding context relevant to these major national payers.
Readers will find an overview of the clinical scope of the code, typical sites of service, and the role of 92523 in care pathways for speech sound disorders. The publication summarizes payer coverage presence, common billing relationships with related SLP codes, and policy references that influence medical necessity determinations for speech evaluations. It also highlights documentation elements that distinguish this in-depth speech production evaluation from other speech and voice assessments. Data not available in the input is noted where applicable.
Customize your policy alerts
Sign up for cpt 92523 policy alerts
Get alerted when payer policies referencing 92523 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 92523 describes an evaluation by a speech–language pathologist (SLP) focused on speech sound production, assessing issues such as incorrect pronunciation and error patterns. The service is an evaluation performed by an SLP to identify articulation and phonological disorders, characterize severity, and guide care planning.
Service Type: Speech–language pathology evaluation (speech sound production).
Typical Site of Service: Outpatient clinics, hospital outpatient departments, rehabilitation centers, schools, and private therapy practices.
National Reimbursement Benchmarks
Medicare’s mean rate for CPT 92523 sits at $234.50, closely aligned with BUCA’s commercial average of $326.80; the commercial average is about $92 higher than Medicare, indicating a modest uplift for commercial contracts relative to Medicare baseline rates. Medians diverge more among commercial payers, with Blue Cross Blue Shield and Cigna showing medians well above Medicare’s central locality value (Medicare p50 $230).
Dispersion measured as P75 minus P25 highlights variability: Cigna’s interquartile spread is $222.10 (P75 $447.20 − P25 $223.10), Blue Cross Blue Shield’s spread is $160.90, UnitedHealth Group’s spread is $189.50, Aetna’s spread is $122.10, and BUCA’s spread is $167.00. Cigna therefore exhibits the widest IQR, while Aetna is the tightest, signaling greater consistency in Aetna’s commercial rates and more variability in Cigna’s.